COGNOSCI, INC.
Biotech · Private
Novel prodrug molecules based on DFMO that inhibit ornithine decarboxylase to reduce polyamines in the brain for Alzheimer's disease treatment
- Grants
- $450K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 2 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Antagonizing the SET Oncoprotein | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Orally-Available Prodrugs for Alzheimer's Disease | $225,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2712 | ENCUE INC. | — | — |
| 2713 | Immune Response BioPharma, Inc. | — | $1.0B |
| 2714 | Foghorn Therapeutics | — | — |
| 2715 | COGNOSCI, INC. | — | — |
| 2716 | IMPLICYTE, INC. | — | — |
| 2717 | OnRamp Digital, Inc. | — | $360K |
| 2718 | Mendra | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Apoe Peptide Dimers And Uses Thereofgranted
- Apoe Peptide Dimers And Uses Thereofgranted
- Methods Of Treating Cancer With Apoe Peptidesapplication
- Methods Of Inhibiting Calcineurin With Apoe Analogsapplication
- Methods For Modulating Set And Uses Thereofapplication
- Improved Apo E Analogs And Methods For Their Useapplication
- Methods Of Suppressingmicroglial Activation And Systemic Inflammatory Responsesapplication
- Apoe Peptide Dimers And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.